GEN Exclusives

More »

GEN News Highlights

Back to Item »

€1.2M Dutch Credit Will Support Phase I/II Trial of to-BBB’s Brain Cancer Drug

Money is expected to cover 35% of costs to develop 2B3-101 as a treatment for patients whose cancer has metastasized to the brain.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?